vs
ANAPTYSBIO, INC（ANAB）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
null的季度营收约是ANAPTYSBIO, INC的1.1倍（$117.3M vs $108.2M），ANAPTYSBIO, INC净利率更高（45.8% vs -7.3%，领先53.1%），ANAPTYSBIO, INC同比增速更快（151.1% vs 5.3%），过去两年ANAPTYSBIO, INC的营收复合增速更高（288.3% vs -14.4%）
AnaptysBio是一家处于临床阶段的生物技术企业，专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法，主要面向美国市场，推进创新候选药物管线研发以满足未被满足的临床需求。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
ANAB vs SWIM — 直观对比
营收规模更大
SWIM
是对方的1.1倍
$108.2M
营收增速更快
ANAB
高出145.8%
5.3%
净利率更高
ANAB
高出53.1%
-7.3%
两年增速更快
ANAB
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $108.2M | $117.3M |
| 净利润 | $49.6M | $-8.5M |
| 毛利率 | — | 31.7% |
| 营业利润率 | 61.8% | — |
| 净利率 | 45.8% | -7.3% |
| 营收同比 | 151.1% | 5.3% |
| 净利润同比 | 327.8% | -43.1% |
| 每股收益（稀释后） | $1.64 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANABSWIM
| Q1 26 | — | $117.3M | ||
| Q4 25 | $108.2M | $100.0M | ||
| Q3 25 | $76.3M | $161.9M | ||
| Q2 25 | $22.3M | $172.6M | ||
| Q1 25 | $27.8M | $111.4M | ||
| Q4 24 | $43.1M | $87.3M | ||
| Q3 24 | $30.0M | $150.5M | ||
| Q2 24 | $11.0M | $160.1M |
净利润ANABSWIM
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $49.6M | $-7.0M | ||
| Q3 25 | $15.1M | $8.1M | ||
| Q2 25 | $-38.6M | $16.0M | ||
| Q1 25 | $-39.3M | $-6.0M | ||
| Q4 24 | $-21.8M | $-29.2M | ||
| Q3 24 | $-32.9M | $5.9M | ||
| Q2 24 | $-46.7M | $13.3M |
毛利率ANABSWIM
| Q1 26 | — | 31.7% | ||
| Q4 25 | — | 28.0% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 33.1% |
营业利润率ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | 61.8% | -10.7% | ||
| Q3 25 | 45.5% | 13.3% | ||
| Q2 25 | -117.5% | 14.3% | ||
| Q1 25 | -99.2% | -4.4% | ||
| Q4 24 | -22.4% | -14.9% | ||
| Q3 24 | -75.8% | 8.9% | ||
| Q2 24 | -367.5% | 12.5% |
净利率ANABSWIM
| Q1 26 | — | -7.3% | ||
| Q4 25 | 45.8% | -7.0% | ||
| Q3 25 | 19.8% | 5.0% | ||
| Q2 25 | -173.5% | 9.3% | ||
| Q1 25 | -141.6% | -5.4% | ||
| Q4 24 | -50.5% | -33.4% | ||
| Q3 24 | -109.4% | 3.9% | ||
| Q2 24 | -425.3% | 8.3% |
每股收益（稀释后）ANABSWIM
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $1.64 | $-0.06 | ||
| Q3 25 | $0.52 | $0.07 | ||
| Q2 25 | $-1.34 | $0.13 | ||
| Q1 25 | $-1.28 | $-0.05 | ||
| Q4 24 | $-0.63 | $-0.24 | ||
| Q3 24 | $-1.14 | $0.05 | ||
| Q2 24 | $-1.71 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | — |
| 总债务越低越好 | — | $3.3M |
| 股东权益账面价值 | $37.2M | $396.7M |
| 总资产 | $364.4M | $856.4M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | $238.2M | — | ||
| Q3 25 | $109.8M | — | ||
| Q2 25 | $44.3M | — | ||
| Q1 25 | $98.6M | — | ||
| Q4 24 | $123.1M | — | ||
| Q3 24 | $191.6M | — | ||
| Q2 24 | $71.8M | — |
总债务ANABSWIM
| Q1 26 | — | $3.3M | ||
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M |
股东权益ANABSWIM
| Q1 26 | — | $396.7M | ||
| Q4 25 | $37.2M | $405.9M | ||
| Q3 25 | $-29.4M | $408.4M | ||
| Q2 25 | $-44.7M | $398.4M | ||
| Q1 25 | $34.0M | $381.1M | ||
| Q4 24 | $70.9M | $387.2M | ||
| Q3 24 | $84.4M | $416.6M | ||
| Q2 24 | $9.9M | $408.1M |
总资产ANABSWIM
| Q1 26 | — | $856.4M | ||
| Q4 25 | $364.4M | $823.2M | ||
| Q3 25 | $353.1M | $844.4M | ||
| Q2 25 | $335.3M | $822.1M | ||
| Q1 25 | $422.1M | $824.6M | ||
| Q4 24 | $483.8M | $794.2M | ||
| Q3 24 | $493.4M | $853.4M | ||
| Q2 24 | $427.4M | $830.0M |
负债/权益比ANABSWIM
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | — |
| 自由现金流率自由现金流/营收 | 90.5% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.98× | — |
| 过去12个月自由现金流最近4个季度 | $19.6M | — |
8季度趋势，按日历期对齐
经营现金流ANABSWIM
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $98.0M | $23.3M | ||
| Q3 25 | $-27.4M | $51.0M | ||
| Q2 25 | $-40.2M | $36.0M | ||
| Q1 25 | $-10.7M | $-46.9M | ||
| Q4 24 | $-66.7M | $6.2M | ||
| Q3 24 | $-10.1M | $37.2M | ||
| Q2 24 | $-21.3M | $52.4M |
自由现金流ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | $98.0M | $14.1M | ||
| Q3 25 | $-27.4M | $45.2M | ||
| Q2 25 | $-40.3M | $29.1M | ||
| Q1 25 | $-10.7M | $-50.3M | ||
| Q4 24 | $-66.9M | $-98.0K | ||
| Q3 24 | $-10.1M | $33.2M | ||
| Q2 24 | $-21.4M | $47.9M |
自由现金流率ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | 90.5% | 14.1% | ||
| Q3 25 | -35.9% | 27.9% | ||
| Q2 25 | -180.9% | 16.8% | ||
| Q1 25 | -38.7% | -45.2% | ||
| Q4 24 | -155.3% | -0.1% | ||
| Q3 24 | -33.7% | 22.1% | ||
| Q2 24 | -194.6% | 29.9% |
资本支出强度ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 9.2% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.2% | 4.0% | ||
| Q1 25 | 0.1% | 3.1% | ||
| Q4 24 | 0.6% | 7.2% | ||
| Q3 24 | 0.1% | 2.7% | ||
| Q2 24 | 0.3% | 2.8% |
现金转化率ANABSWIM
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | -1.81× | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
